Editorial

Doing something about aging seems to require action at the most basic genomic level. Here's what's been done there and in other areas in June. Interviews The Thalion Initiative: A New Non-Profit With Big Ambitions: The longevity field remains small and starved for resources, especially the subfield devoted to the fundamental biology of aging, despite...

Approaches that modify the processes of aging at their roots have gone well beyond basic research and into therapies intended for the clinic within the next few years. Here's how the field has advanced in May. Team and activities The Longevity Investor Network Looks Back at 2025: Through curated monthly pitch sessions, educational seminars, collaborative...

The Longevity Investor Network (LIN) was created to help bridge the gap between promising longevity startups and the investors capable of helping them scale. Through curated monthly pitch sessions, educational seminars, collaborative diligence, and ecosystem-building events, LIN provides a structured platform for investors to discover, evaluate, and support companies working at the forefront of aging...

For many hundreds of years, Easter has been associated with rebirth and rejuvenation. Let's see what's been done last month to rejuvenate animals and people. Team and Activities Support the Human Ageing Genomic Resources: João Pedro de Magalhães has launched a fundraiser to help maintain this database, which has supported thousands of scientists worldwide in...

Plenty of crucial work has been done in the rejuvenation world over the past four weeks, and last month, we've spoken to several researchers about the progress being made. Interviews João Pedro de Magalhães on the Ethics of Longevity: João Pedro de Magalhães, professor at the University of Birmingham, is a skilled longevity advocate who...

2026 has kicked off with several key research insights, and we've taken a look at the state of the industry and how rejuvenation biotechnology is moving forward. Here's what's been done in January. Advocacy and Analysis Longevity Biotech in 2025: The Expert Roundup: How did the year 2025 turn out for longevity biotech? Was it...